...
首页> 外文期刊>Science of the total environment >Proposal for fluorescence-based in vitro assay using human and zebrafish monoamine transporters to detect biological activities of antidepressants in wastewater
【24h】

Proposal for fluorescence-based in vitro assay using human and zebrafish monoamine transporters to detect biological activities of antidepressants in wastewater

机译:使用人和斑马鱼单胺转运蛋白基于荧光的体外测定的提议检测废水中抗抑郁药的生物学活性

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Antidepressants are among the most commonly detected Pharmaceuticals in the aquatic environment. As they modulate neurotransmission in nervous systems, behavioural abnormalities among aquatic species are of concern. It is possible to measure the concentrations of selected antidepressants by chemical analysis, but other non-target antidepressants and active metabolites might also be present. Here, we propose an "in vitro monoamine transporter inhibition assay" to measure the biological activity of antidepressants, particularly monoamine transporter inhibitors, in wastewater. We used APP, a fluorescent substrate for monoamine transporters, to measure the activity of wastewater extracts at inhibiting APP uptake through the human serotonin transporter (hSERT), norepinephrine transporter (hNET), and dopamine transporter, and the zebrafish SERT (zSERT). We confirmed that the assay could measure the biological activity of test antidepressants. Interestingly, the IC_(50) values of antidepressants (the concentration that gave a 50% reduction of APP uptake) for the zSERT were smaller than those for the hSERT. For example, IC_(50) value of desipramine for the zSERT was 1 /200 of that for the hSERT. These results indicate that antidepressants inhibited zSERT more strongly than hSERT. Then we applied the assay to extracts of effluent from municipal wastewater treatment plants and detected biological activity of antidepressants specifically against the hSERT, hNET, and zSERT for the first time. For the hSERT, antidepressant-equivalent quantities (EQs) ranged from 2.2 × 10~1 to 2.5 × 10~2 ng-clomipramine-EQ/L For the hNET, EQs ranged from below limit of detection to 8.2 × 10~1 ng-desipramine-EQ/L For the zSERT, EQs ranged from 2.8 × 10~2 to 3.3 × 10~2 ng-duloxetine-EQ/L. The in vitro monoamine transporter inhibition assay is thus useful for measuring the biological activity of antidepressants in the aquatic environment
机译:抗抑郁药是水生环境中最常见的药物之一。随着它们调节神经系统的神经递质,水生物种之间的行为异常是关注的。可以通过化学分析测量所选抗抑郁药的浓度,但也可以存在其他非靶抗抑郁药和活性代谢物。在这里,我们提出了“体外单胺转运蛋白抑制测定”,以测量废水中抗抑郁药,特别是单胺转运蛋白抑制剂的生物活性。我们使用过应用的荧光基底用于单胺转运蛋白,测量通过人血清素转运蛋白(HSERT),去甲肾上腺素转运蛋白(HSERT),Norepinephrine转运蛋白(HNET)和多巴鱼SERT(ZSERT)的废水提取物的活性。我们证实,测定可以测量试验抗抑郁药的生物活性。有趣的是,抗抑郁药的IC_(50)的抗抑郁药(浓度为ZSERT的50%浓度)小于HSERT的抗抑郁剂的50%的浓度。例如,Zsert的Desipramine的IC_(50)值为HSERT的1/200。这些结果表明抗抑郁药比HSERT更强烈地抑制ZSERT。然后,我们将该测定应用于从城市废水处理厂的污水中提取物,并首次检测特异性抵抗HSERT,HNET和ZSERT的抗抑郁药的生物活性。对于HSERT,抗抑郁当量量(EQS)为HNET的2.2×10〜1至2.5×10〜2 Ng-Clomipramine-eq / L,EQS从低于检测限额为8.2×10〜1 ng- Zsert的Desipramine-eq / L,等式的平均范围为2.8×10〜2至3.3×10〜2 ng-duloxetine-eq / L.因此,体外单胺转运蛋白抑制测定可用于测量水生环境中抗抑郁药的生物活性

著录项

  • 来源
    《Science of the total environment》 |2021年第20期|144665.1-144665.13|共13页
  • 作者单位

    Research Center for Environmental Quality Management Kyoto University 1-2 Yumihama Otsu Shiga 520-0811 Japan;

    Research Center for Environmental Quality Management Kyoto University 1-2 Yumihama Otsu Shiga 520-0811 Japan;

    Research Center for Environmental Quality Management Kyoto University 1-2 Yumihama Otsu Shiga 520-0811 Japan;

    Research Center for Environmental Quality Management Kyoto University 1-2 Yumihama Otsu Shiga 520-0811 Japan;

    Research Center for Environmental Quality Management Kyoto University 1-2 Yumihama Otsu Shiga 520-0811 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Antidepressant; In vitro assay; Monoamine transporter; Zebrafish; Human; Wastewater;

    机译:抗抑郁药;体外测定;单胺运输车;斑马鱼;人类;废水;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号